Barely Significant
← all excerpts

Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: Data from an early-access program in Italy.

Eur J Neurol · 2022 · PMC9314115 · PMID 35289020

Europe PMCDOI
1
hedged sentence
0.0530
closest p · 1.1× alpha
0.0530
boldest claim

The sentences

almost significantp = 0.053so close (0.05 < p ≤ 0.1)
We found an almost significant worsening of NIS values ( p = 0.053) from baseline to M24 (Supplementary Figure S2 ); however, we should consider that only four patients (two FAP 2 and two FAP 3) reached this follow‐up.

also in 1,858 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.